Reimbursement
Three upcoming hearings will focus on controlling opioid misuse, public health and prevention and insurance coverage.
The results of new research conducted by Avalere Health counter the argument that 340B drug pricing would bring dramatic reimbursement cuts to hospitals.
Clinicians who complete the study will earn a full activity credit toward their quality reporting, according to the Centers for Medicare and Medicaid Services.
The company had planned to reduce by 25 percent payments for evaluation and management services reported with modifier.
Non-adherent patients are three times more likely to be readmitted to the hospital within 30 days.
Insurers have sued over the lack of payments that were part of Affordable Care Act measures to make up for any losses in the marketplace.
Hospitals could be staring down bigger competition, declining volume and shrinking margins as organizations such as OptumCare stake a bigger claims in the provider space.
Researchers at Boston Medical, Mass General and Stanford said screening more people for the virus increases cure rates and reduces deaths.
Readmissions cost the healthcare system an estimated $17 billion annually and the majority are avoidable.
The payer organization will hold two conferences back-to-back in Washington, D.C. during March.